Your session is about to expire
← Back to Search
Behavioural Intervention
Speech Perception Assessment via Mobile App for Hearing Loss (VALDE-MU Trial)
N/A
Recruiting
Research Sponsored by Cochlear
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day - immediately post screening.
Awards & highlights
VALDE-MU Trial Summary
This trial will study how a mobile app can measure & validate hearing in adults who have cochlear implants.
Who is the study for?
This trial is for adults over 18 who use a hearing device, are fluent in the language of the speech perception test, and can consent to participate. It's not for Cochlear employees, those involved in other drug/device trials within 30 days, or pregnant women.Check my eligibility
What is being tested?
The study tests a Mobile Research App designed to measure speech perception in adult cochlear implant users. It's an international feasibility study comparing app results with standard-of-care methods.See study design
What are the potential side effects?
Since this trial involves a non-invasive mobile app for testing speech perception and does not include drugs or invasive procedures, there are no direct physical side effects associated with its use.
VALDE-MU Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 day - immediately post screening.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day - immediately post screening.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
To determine if test-retest reliability
VALDE-MU Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Delivery of speech perception materials using the experimental method (Mobile Research App)Experimental Treatment1 Intervention
Group II: Delivery of speech perception materials using the experimental method (MRA) in home environmentExperimental Treatment1 Intervention
Group III: Standard of Care validated delivery of speech perception materialsActive Control1 Intervention
Find a Location
Who is running the clinical trial?
CochlearLead Sponsor
90 Previous Clinical Trials
6,033 Total Patients Enrolled
81 Trials studying Hearing Loss
5,764 Patients Enrolled for Hearing Loss
Share this study with friends
Copy Link
Messenger